MYCIO Wealth Partners’s Kyntra Bio KYNB Stock Holding History

MYCIO Wealth Partners’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-260	Closed	-$279K	–	146
2019 Q4	$279K	Buy	+260	New	+$265K	0.02%	279

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

MYCIO Wealth Partners's KYNB Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 260 shares — an estimated $279K sold.

MYCIO Wealth Partners first reported a position in KYNB in Q4 2019 and held it in 1 quarter. The position peaked at $279K in Q4 2019. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

MYCIO Wealth Partners reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
MYCIO Wealth Partners sold 260 Kyntra Bio shares in Q1 2020, an estimated $279K.
MYCIO Wealth Partners first reported a position in Kyntra Bio in Q4 2019 and held it in 1 quarter.
MYCIO Wealth Partners's Kyntra Bio position peaked at $279K in Q4 2019.
187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.